Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies

Blood

Volumn 91, Issue 6, 1998, Pages 1845-1851

  Yokoyama, Akihiro ^b   Okabe Kado, Junko ^a   Wakimoto, Naoki ^b   Kobayashi, Hirofumi ^b   Sakashita, Akiko ^b   Maseki, Nobuo ^b   Nakamaki, Tsuyoshi ^b   Hino, Ken Ichiro ^b   Tomoyasu, Shigeru ^b   Tsuruoka, Nobuyoshi ^b   Motoyoshi, Kazuo ^b   Nagata, Naokazu ^b   Honma, Yoshio ^b  

^a SAITAMA CANCER CENTER   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION INHIBITORY FACTOR NM23; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032521489     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.1845     Document Type: Article

References (38)

1. Okabe-Kado J, Kasukabe T, Honma Y, Hayashi M, Henzel WJ, Hozumi M: Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase. Biochem Biophys Res Commun 182:987, 1992
2. Okabe-Kado J, Kasukabe T, Hozumi M, Honma Y, Kimura N, Baba H, Urano T, Shiku H: A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require its kinase activity. FEBS Lett 363:311, 1995
3. Okabe-Kado J, Kasukabe T, Baba H, Urano T, Shiku H, Honma Y: Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells. Biochim Biophys Acta 1267: 101, 1995
4. Keim D, Hailat N, Melhem R, Zhu XX, Lascu I, Veron M, Stahlen J, Hanash S M: Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 89:919, 1992
5. Yamashiro S, Urano T, Shiku H, Furukawa K: Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines. Oncogene 9:2461, 1994
6. Yokoyama A, Okabe-Kado J, Sakashita A, Maseki N, Kaneko Y, Hino K, Tomoyasu S, Tsuruoka N, Kasukabe T, Honma Y: Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia. Blood 88:3555, 1996
7. Aryee DNT, Simonitsch I, Mosberger I, Kos K, Mann G, Schlogl E, Potschger U, Gander H, Radaszkiewicz T, Kovar H: Variability of nm23-H1//NDPK-A expression in human lymphomas and its relation to tumour aggressiveness. Br J Cancer 74:1693, 1996
8. AML-87 Study of the Japan Adult Leukemia Study Group: Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. Cancer 71:3888, 1993
9. Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamoto A, Norio A, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, Hiraoka A, Yamada O, Oh H, Furusawa S, Matsuda S, Naoe T: All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan. Leukemia 8:64, 1994 (suppl 3)
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by guanidinium thiocyanat e-phenol-chloroform extraction. Anal Biochem 162:156, 1987
11. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80:200, 1988
12. MacDonald NJ, Rosa ADL, Steeg PS: The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 31A: 1096, 1995
13. Leone A, Flatow U, King CR, Sandeen MA, Margulies IMK, Liotta LA, Steeg PS: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm25-transfected melanoma cells. Cell 65:25, 1991
14. Leone A, Flatow U, VanHoutte K, Steeg PS: Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization, and enzymatic activity. Oncogene 8:2325, 1993
15. Baba H, Urano T, Okada K, Furukawa K, Nakayama E, Tanaka H, Iwasaki K, Shiku H: Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res 55:1977, 1995
16. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49:5185, 1989
17. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N, Nagataki S: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84:1349, 1992
18. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M: Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: Correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res 54:1825, 1994
19. Nakayama H, Yasui W, Yokozaki H, Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84:184, 1993
20. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland ØS, Fodstad Ø: Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression. Cancer Res 52:6088, 1992
21. Rosa ADL, Williams RL, Steeg PS: Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functions. Bioessays 17:53, 1994
22. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8:855, 1993
23. Nakamori S, Ishikawa O, Ohhigashe H, Kameyama M, Furukawa H, Sasaki Y, Inaji H, Higashiyama M, Imaoka S, Iwanaga T, Funai H, Wada A, Kimura N: Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: An association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 11:151, 1993
24. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51:445, 1991
25. Gilles AM, Presecan E, Vonica A, Lascu I: Nucleoside diphosphate kinase from human erythrocytes. J Biol Chem 266:8784, 1991
26. Chandrasekharappa SC, Gross LA, King SE, Collins FS: The human NME2 gene lies within 18kb of NME1 in chromosome 17. Genes Chromosom Cancer 6:245, 1993
27. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RL, Shows TB, Methew S, Murty VVVS, Chaganti RSK: Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 8:497, 1993
28. Okada K, Urano T, Goi T, Baba H, Yamaguchi A, Furukawa K, Shiku H: Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. Cancer Res 54:3979, 1994
29. Okada K, Urano T, Baba H, Furukawa K, Furukawa K, Shiku H: Independent and differential expression of two isotypes of human Nm23: Analysis of the promoter regions of the nm23-H1 and H2 genes. Oncogene 13:1937, 1996
30. Postel EH, Berberich SJ, Flint SJ, Ferrone CA: Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261:478, 1993
31. Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S: Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature 322:748, 1986
32. Prochownik EV, Kukowska J: Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature 322:848, 1986
33. Okabe-Kado J: Factors inhibiting differentiation of myeloid leukemia cells. Crit Rev Oncog 3:293, 1992
34. Ferguson AW, Flatow U, MacDonald NJ, Larminat F, Bohr VA, Steeg PS: Increased sensitivity to cisplatin by nm23-transfected tumor cell lines. Cancer Res 56:2931, 1996
35. Honma Y, Kasukabe T, Hozumi M: Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells. J Natl Cancer Inst 61:837, 1978
36. Okabe-Kado J, Hayashi M, Honma Y, Hozumi M: Characterization of a differentiation-inhibitory activity from nondifferentiating mouse myeloid leukemia cells. Cancer Res 45:4848, 1985
37. Okabe-Kado J, Kasukabe T, Honma Y, Hayashi M, Hozumi M: Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiatingmouse myeloid leukemia cells. J Biol Chem 263:10994, 1988
38. Venturelli D, Martinez R, Melotti P, Casella I, Peschle C, Cucco C, Spampinato G, Darzynkiewicz Z, Calabretta B: Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc Natl Acad Sci USA 92:7435, 1995